User: TahirAmin Topic: IP
Category: drugs :: everywhere
Last updated: Jun 26 2017 21:37 IST RSS 2.0
 
1 to 20 of 9,671    
EU tests limits of drug pricing freedom in landmark probe 26.6.2017 Sify Finance
By Foo Yun Chee and Ben Hirschler
Also found in: [+]
ANALYSIS-EU tests limits of drug pricing freedom in landmark probe 26.6.2017 DNA: Health
The first ever EU antitrust probe into excessive drug pricing is taking the European pharmaceuticals industry into uncharted territory, unnerving some companies and lawyers worried about the reach of market intervention.
Also found in: [+]
Activists warn of US pressure to change drug regulatory system 26.6.2017 DNA: Health
In the past, the US government has successfully pressurised India to change its pro-public health stance, and there may be renewed demands for more concessions
Also found in: [+]
Modi urged to remain committed to affordable drugs during meeting with Trump 24.6.2017 TOI: India
Also found in: [+]
Modi urged to remain committed to affordable dedicines during meeting with Trump 23.6.2017 TOI: India
Also found in: [+]
EU backs second biosimilar copy of Humira, world's top drug 23.6.2017 TOI: All Headlines
EU backs second biosimilar copy of Humira, world's top drug
Also found in: [+]
Global pharma sales face $60 bn hit due to pricing scrutiny: market study 21.6.2017 All Companies Stories
A report by market intelligence firm Evaluate has cut five year global pharmaceutical sales forecast by $ 390 billion amid rising scrutiny of drug pricing and price erosion in various markets.The report states that patent expiries of drugs valuing $ 194 billion will erode sales of multi national pharma companies but this will benefit Indian drug makers which continue to face challenges due to pricing pressure and regulatory issues.Evaluate estimates global pharmaceutical sales at $ 1.06 trillion in 2022 down from $ 1.12 trillion forecast for the same period last year."This slight retraction is likely due to a number of factors but the continued squeeze on pricing is almost certainly a major one. Although (US president) Donald Trump has yet to directly intervene on the US drug costs, the threat remains ever present and some pharma companies have announced their own pre-emptive strikes by publicly announcing caps to price hikes," Evaluate said in its report. It also cites other ...
Also found in: [+]
Apple tells court Qualcomm chip licenses are invalid 20.6.2017 TOI: All Headlines
Apple tells court Qualcomm chip licenses are invalid
Also found in: [+]
Apple tells court Qualcomm chip licenses are invalid 20.6.2017 DNA: Evolutions
Apple Inc broadened a legal attack on Qualcomm Inc, arguing to a U. S. federal court that license agreements that secure the chip maker a cut of every iPhone manufactured were invalid.
Also found in: [+]
Cancer drug: SC allows Cipla to withdraw appeal against Roche 16.6.2017 deccanherald.com
The Supreme Court today allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row. The apex court was informed that the two companies on May 30 had arrived at a settlement before the Delhi High Court to close the patent dispute between them over the drug erlotinib hydrochloride, manufactured and sold by Roche under the name of Tarceva and Ciplas Erlocip. Cipla had filed a petition challenging the High Courts November 27, 2015 order holding that it had infringed Roches patent in a lung cancer drug. However, after the May 30 settlement, Cipla moved the apex court seeking to withdraw the Special Leave Petition (SLP) filed against the 2015 decision. Ciplas lawyer mentioned the matter before a bench of Justices R K Agrawal and S K Kaul and said both the firms -- Cipla Ltd and F Hoffmann-La Roche Ltd-- have arrived at a settlement over the dispute and now they do not want to pursue the ...
Also found in: [+]
Cancer drug: Supreme Court allows Cipla to withdraw appeal against Roche 16.6.2017 News
The single judge had also refused to revoke the patent of the Swiss company as sought by Cipla
Also found in: [+]
Suven Life gets patents for anti-neuro degeneration molecule 13.6.2017 ET: Pharma
The molecules are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's disease.
Also found in: [+]
Suven Life gets patents for anti-neuro degeneration molecule 13.6.2017 DNA: Health
Drug firm Suven Life Sciences has received one product patent each from Australia and the US for its molecule to be used in the treatment of neuro- degenerative diseases.
Also found in: [+]
How a leadership flux, and consequent tinkering in strategy has taken a toll on Cipla 13.6.2017 ET: Pharma
Heads of Europe and US operations Frank Pieters and Tim Crew are both gone, as is Subhanu Saxena, the MD who was hired from Novartis in 2012.
Also found in: [+]
U.S. Supreme Court speeds copycat biologic drugs to market 13.6.2017 Sify Finance
By Andrew Chung
Also found in: [+]
U.S. Supreme Court speeds copycat biologic drugs to market 12.6.2017 DNA: Health
The U. S. Supreme Court on Monday cut the time it will take for copycat versions of biologic drugs to get to the market in a pivotal ruling about an expensive class of medicines that can yield billions of dollars in sales for drug companies.
Also found in: [+]
Dilip Shanghvi repositions Sun Pharma in US as a specialty drugmaker 7.6.2017 Business Standard: News Now
Company has lost 50% market value in 2 years due to competition
Also found in: [+]
FDA nod for generic Lialda launch to boost US biz for Zydus Cadila in FY18 7.6.2017 Latest News
Market for the drug, which could be a key growth driver for firm's US business, is pegged at $1.1 bn
Also found in: [+]
Zydus Cadila gets USFDA nod to market ulcerative colitis drug 7.6.2017 Latest News
Market for the drug, which could be a key growth driver for firm's US business, is pegged at $1.1 bn
Also found in: [+]
Bharat Biotech's chikangunya vaccine enters clinical trials 5.6.2017 DNA: Health
Bharat Biotech today said that the phase 1 human clinical trials of the indigenously developed chikungunya (CHIKV) vaccine is underway in India to evaluate its safety, tolerability and immunogenicity.
Also found in: [+]
1 to 20 of 9,671